新闻室

Filter By:
新闻室
18-07-2018

Frontage acquires Concord Biosciences

Frontage Laboratories, Inc., a global CRO with headquarters in Exton, Pennsylvania, announces the acquisition of Concord Biosciences, formerly known as Ricerca Biosciences, LLC, a preclinical CRO located near Cleveland, Ohio. Founded in 1986, Concord Bio supports the pharmaceutical, agricultural, chemical, and animal health industries with Drug Safety, Metabolism, Bioanalytical, Residue, and Environmental Fate studies.
查看详情
新闻室
17-07-2018

Frontage Receives 2018 CRO Leadership Awards

Exton, P.A., July 11, 2018: Frontage Laboratories, Inc. has been named as a 2018 CRO Leadership Awards recipient by Life Science Leader magazine. The publication annually asks pharmaceutical and biopharmaceutical companies to rate the capability and performance of contract research organizations.
查看详情
新闻室
21-06-2018

Frontage Appoints Hugh Davis as Chief Business Officer

Frontage Laboratories, Inc., is pleased to announce the appointment of Dr. Hugh Davis as Chief Business Officer (CBO), in charge of Business Development, Sales, Marketing and Strategic Partnerships.
查看详情
新闻室
21-06-2018

Dr. Song Li Wins Healthcare CEO Enterprise Award

Dr. Song Li, Founder and CEO of Frontage Laboratories, Inc., has been awarded the Healthcare CEO of the Year Enterprise Award for 2018.
查看详情
新闻室
21-06-2018

Dr. Song Li Awarded Entrepreneur Of The Year?

Dr. Song Li, Founder and CEO of Frontage Laboratories, Inc., has been awarded the Entrepreneur Of The Year?Award for 2018.
查看详情
新闻室
02-05-2018

Frontage announces that Dr. Philip Doren has joined Frontage as the President of Clinical Services

Today, Frontage announces that Dr. Philip Doren has joined Frontage as the President of Clinical Services. He will help Frontage to evaluate and secure early clinical and biometric opportunities and develop relationships with strategic partners to expand our services in key areas of support.
查看详情